Dipesh K. Uprety

Dipesh K. Uprety

Hematology Oncology

22 South Greene Street
Floor 1
Baltimore, MD 21201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

20 Years of Breakthroughs: Transforming the Fight Against Thoracic Malignancies.

20 Years of Breakthroughs: Transforming the Fight Against Thoracic Malignancies.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 10, 2025

Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis.

Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis.

Journal: Clinical lung cancer

Published: June 10, 2025

Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Journal: Cancer

Published: May 13, 2025

50 Years of Progress in NSCLC: A New Fellow's Guide in the Clinic.

50 Years of Progress in NSCLC: A New Fellow's Guide in the Clinic.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 03, 2025

Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and Outcomes.

Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and Outcomes.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 29, 2025

Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER Database.

Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER Database.

Journal: Cancer medicine

Published: October 23, 2024

Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study.

Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 22, 2024

Adjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant Immunotherapy.

Adjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant Immunotherapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 19, 2024

Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens.

Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens.

Journal: bioRxiv : the preprint server for biology

Published: September 30, 2024

Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma.

Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma.

Journal: BMJ oncology

Published: July 23, 2024

Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based study.

Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database-based study.

Journal: Cancer

Published: February 23, 2024

Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors.

Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors.

Journal: Therapeutic advances in vaccines and immunotherapy

Published: February 06, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026